e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cell biology of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
F. Stellari, F. Ricci, P. Caruso, L. Calza‘, R. Ruotolo, L. Lorenzini, G. Villetti (Parma, Bologna, Italy)
Source:
Annual Congress 2011 - Cell biology of lung disease
Session:
Cell biology of lung disease
Session type:
Thematic Poster Session
Number:
3879
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Stellari, F. Ricci, P. Caruso, L. Calza‘, R. Ruotolo, L. Lorenzini, G. Villetti (Parma, Bologna, Italy). In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response. Eur Respir J 2011; 38: Suppl. 55, 3879
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
High proteasome activity and absence of NF-kB activation in cystic fibrosis cell culture and CF KO mouse models in response to oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
Characterization of the Toll-IL-1 pathway gene profile in an
in-vitro
model of chronic airway inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Ozone induced acute and chronic alterations in the lung in mice: a combined digital imaging and functional analysis.
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Repeated stress modulates lung tissue mechanics and induces pulmonary inflammation, remodelling and oxidative stress pathway activation in guinea pigs
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis
ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017
Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury
Source: Eur Respir J, 58 (6) 2102238; 10.1183/13993003.02238-2021
Year: 2021
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Febrile-range hyperthermia augments lung injury through a mechanism involving death receptor signaling
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Glucocorticoid receptor expression in different rat models of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
Differential effects of pharmacological leukotriene pathway modulators in a human lung tissue explant model
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept